What is a ViE Award?

The 2nd annual Vaccine Industry Excellence Awards will once again be an integral part of the annual World Vaccine Congress Washington. Taking place during the evening of the 21st April 2009, the ViE Awards will be recognising the outstanding achievements of vaccine practitioners and stakeholders across the global industry.

» Reserve your seat now 

World Vaccine Congress Washington - The conference

Attracting over 380 attendees, from across the globe, the World Vaccine Congress Washington is firmly established as the premier meeting place of the vaccine industry. It is where the global vaccine community comes to meet, network and do business, making it the perfect time and place to celebrate and recognise the industry’s most outstanding achievements.

» View conference website
» Reserve your conference seat now

Best Contract Research Organisation

• Accelovance
• Covance
• Encorium
• ICON Clinical Research
• Quintiles
• PPD
• SNBL

Best Contract Manufacturing Organisation

• Cobra Biomanufacturing
• Eden Biodesign
• Diosynth Biotechnology
• Lonza
• SAFC Pharma
• SynCo Bio Partners

Best Early-Stage Vaccine Biotech
Sponsored by ICON Clinical Research

• ApoImmune
• LigoCyte Pharmaceuticals
• InViragen
• NanoBio Corporation
• Novavax
• Profectus BioSciences
• Sanaria
• Vaxine
• VLP Biotech

Biotech CEO of the Year

• Dr Ronald Brus, Chief Executive Officer, Crucell
• Mr Fuad El-Hibri, Chief Executive Officer, Emergent Biosolutions
• Dr Robert McNally, Chief Executive Officer, GeoVax
• Mr Brian McNamee, Chief Executive Officer, CSL Ltd.
• Mr Robert Paull, former Chief Executive Officer, Genocea Biosciences
• Dr Gerd Zettlmeissl, Chief Executive Officer, Intercell

Best Vaccine Partnership / Alliance

• GlaxoSmithKline Biologicals and PATH Malaria Vaccine Initiative
• Merck and Intercell
• sanofi pasteur and Acambis
• Novartis Vaccines and Intercell

Best Vaccine R&D Pipeline
Sponsored by Quintiles

• GlaxoSmithKline Biologicals
• Novartis Vaccine and Diagnostics
• sanofi pasteur

Best Therapeutic Vaccine
(approved or in development)

• Oncophage from Antigenics
• NeuVax from Apthera
• MAGE-A3 (ASCI) from GlaxoSmithKline Biologicals
• NicVAX from Nabi Biopharmaceuticals

Best Prophylactic Vaccine
(approved or in development)
Sponsored by CSL Biotherapies

• rF1V Plague from DVC LLC
• Group A Streptococci (GAS) from Vaxent
• RotaTeq from Merck
• Ixiaro from Novartis Vaccines
• Pentacel from sanofi pasteur

Pharma Vaccine Executive of the Year

• Mr Jean Stéphenne, President and General Manager, GlaxoSmithKline Biologicals
• Dr Rino Rappuoli, Global Head of Vaccine Research, Novartis Vaccines and Diagnostics
• Mr Wayne Pisano, Chief Executive Officer, sanofi pasteur